Ruxolitinib 20mg tablets
NHS hospitals in England used £21,996,080 of indicative cost of Ruxolitinib 20mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 17.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ruxolitinib 20mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ruxolitinib 20mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £1,720,740 |
| Western Sussex Hospitals Nhs Found Trust | £753,270 |
| University College London Foundation Tr | £621,164 |
| University Hpls Of Leicester Nhs Trust | £544,782 |
| Oxford University Hospitals Nhs Ft | £538,254 |
| South Tyneside And Sunderland Nhs Ft | £527,136 |
| Univ Hpl B/Ham Nhs Foundation Trust | £504,084 |
| Derby Teaching Hospitals Nhs Found Trust | £499,290 |
| Southend Univ Hosp Nhs Foundation Trust | £488,376 |
| Univ Hpls Bristol Nhs Foundation Trust | £429,012 |
The primary-care picture
Ruxolitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ruxolitinib medicine page.